<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Transition Therapeutics Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Transition Therapeutics Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Transition_Therapeutics_Inc-2519667</link>
<lastBuildDate>19 Mar 2010 05:23:18 EST</lastBuildDate>
<alacra:xlsid>2519667</alacra:xlsid>
<alacra:company>Transition Therapeutics Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<alacra:host>www.alacrastore.com</alacra:host>
<item><link>http://www.alacrastore.com/storecontent/newstex/PZM-0001-41970490</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PZM-0001-41970490</newstex:docid><guid isPermaLink="false">newstex/PZM-0001-41970490</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) 2010, GlobeNewswire.</newstex:CopyrightHolder><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">Transition Therapeutics Inc.</newstex:CreditLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexPZM-0001-41970490</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">PZM</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07005000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016047</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014014</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014019</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07001000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07001006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003001</newstex:cat><pubDate>10 Feb 2010 05:12:27 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18012000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18022000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002012</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002007</newstex:geo><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">2/10/2010</newstex:loaddate><title>Transition Therapeutics Announces Second Quarter Fiscal 2010 Financial Results</title><description> GlobeNewswire delivered by Newstex) --  TORONTO, Feb. ##, #### (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI), a product-focused biopharmaceutical company developing therapeutics...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TRANSITION THERAPEUTICS INC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TRANSITION THERAPEUTICS INC.</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TTH</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TTHI</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PZM-0001-41871375</link><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PZM-0001-41871375</newstex:docid><guid isPermaLink="false">newstex/PZM-0001-41871375</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><newstex:Contributor xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Contributor><newstex:CopyrightDate xmlns:newstex="http://www.alacra.com/newstex">2005</newstex:CopyrightDate><newstex:CopyrightHolder xmlns:newstex="http://www.alacra.com/newstex">Copyright (c) 2010, GlobeNewswire.</newstex:CopyrightHolder><newstex:CreditLine xmlns:newstex="http://www.alacra.com/newstex">Transition Therapeutics Inc.</newstex:CreditLine><newstex:Provider xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Provider><newstex:ProviderId xmlns:newstex="http://www.alacra.com/newstex">newstex.com</newstex:ProviderId><newstex:PublicIdentifier xmlns:newstex="http://www.alacra.com/newstex">newstexPZM-0001-41871375</newstex:PublicIdentifier><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:Publication><newstex:PublicationCode xmlns:newstex="http://www.alacra.com/newstex">0001</newstex:PublicationCode><newstex:Publisher xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:Publisher><newstex:PublisherCode xmlns:newstex="http://www.alacra.com/newstex">PZM</newstex:PublisherCode><newstex:RevisionId xmlns:newstex="http://www.alacra.com/newstex">1</newstex:RevisionId><newstex:Source xmlns:newstex="http://www.alacra.com/newstex">Newstex Inc.</newstex:Source><newstex:SourceId xmlns:newstex="http://www.alacra.com/newstex">GlobeNewswire</newstex:SourceId><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07005000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><pubDate>08 Feb 2010 08:13:42 EST</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:loaddate xmlns:newstex="http://www.alacra.com/newstex">2/8/2010</newstex:loaddate><title>Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2010 Financial Results on Wednesday, February 10th, at 4:30 P.M. EST</title><description> GlobeNewswire delivered by Newstex) --  TORONTO, Feb. #, #### (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (Nasdaq:TTHI) (TSX:TTH) will hold a conference call on Wednesday, February ##, #### at #:##...</description><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TRANSITION THERAPEUTICS INC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">TRANSITION THERAPEUTICS INC.</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TTH</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">TTHI</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item></channel></rss>